| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Coeptis Therapeutics Holdings, Inc. | Chief Financial Officer | Common Stock | 22,500 | $323,550 | $14.38 | 11 Feb 2026 | Direct |
| Coeptis Therapeutics Holdings, Inc. | Chief Financial Officer | Non-Qualified Stock Options (right to buy) | 22,500 | 04 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| COEP | Coeptis Therapeutics Holdings, Inc. | 11 Feb 2026 | 2 | +$105,600 | 4 | Chief Financial Officer | 13 Feb 2026, 17:00 |
| COEP | Coeptis Therapeutics Holdings, Inc. | 04 Mar 2025 | 1 | $0 | 4 | Chief Financial Officer | 06 Mar 2025, 17:29 |
| COEP | Coeptis Therapeutics Holdings, Inc. | 10 Jan 2024 | 1 | +$3,350 | 4 | Chief Financial Officer | 17 Jan 2024, 16:03 |
| COEP | Coeptis Therapeutics Holdings, Inc. | 10 Jan 2024 | 0 | $0 | 3 | Chief Financial Officer | 17 Jan 2024, 16:01 |